8 research outputs found
Conjugation of Organoruthenium(II) 3-(1H-Benzimidazol-2-yl)pyrazolo[3,4-b]pyridines and Indolo[3,2-d]benzazepines to Recombinant Human Serum Albumin: a Strategy To Enhance Cytotoxicity in Cancer Cells
Five organoruthenium complexes [RuCl(η6-arene)(L)]Cl with a modified arene ligand, namely, 4-formylphenoxyacetyl-η6-benzylamide, and L = 3-(1H-benzimidazol-2-yl)-1H-pyrazolo[3,4-b]pyridines or indolo[3,2-d]benzazepines were synthesized and conjugated to recombinant human serum albumin in order to improve their drug targeting and delivery to cancer cells, and a marked increase in cytotoxicity was observed
Organometallic 3-(1H-Benzimidazol-2-yl)-1H-pyrazolo[3,4-b]pyridines as Potential Anticancer Agents
Dicopper(II) and Dizinc(II) Complexes with Nonsymmetric Dinucleating Ligands Based on Indolo[3,2â<i>c</i>]quinolines: Synthesis, Structure, Cytotoxicity, and Intracellular Distribution
DicopperÂ(II) and
dizincÂ(II) complexes [Cu<sub>2</sub>(<sup>MeOOC</sup>L<sup>COO</sup>)Â(CH<sub>3</sub>COO)<sub>2</sub>] (<b>1</b>)
and [Zn<sub>2</sub>(<sup>MeOOC</sup>L<sup>COO</sup>)Â(CH<sub>3</sub>COO)<sub>2</sub>] (<b>2</b>) were synthesized by reaction of
CuÂ(CH<sub>3</sub>COO)<sub>2</sub>·H<sub>2</sub>O and ZnÂ(CH<sub>3</sub>COO)<sub>2</sub>·2H<sub>2</sub>O with a new nonsymmetric
dinucleating ligand <sup><b>EtOOC</b></sup><b>HL</b><sup><b>COOEt</b></sup> prepared by condensation of 6-hydrazinyl-11<i>H</i>-indoloÂ[3,2-<i>c</i>]Âquinoline with diethyl-2,2âČ-((3-formyl-2-hydroxy-5-methylbenzyl)Âazanediyl)Âdiacetate.
The design and synthesis of this elaborate ligand was performed with
the aim of increasing the aqueous solubility of indoloÂ[3,2-<i>c</i>]Âquinolines, known as biologically active compounds, and
investigating the antiproliferative activity in human cancer cell
lines and the cellular distribution by exploring the intrinsic fluorescence
of the indoloquinoline scaffold. The compounds have been comprehensively
characterized by elemental analysis, spectroscopic methods (IR, UVâvis, <sup>1</sup>H and <sup>13</sup>C NMR spectroscopy), ESI mass spectrometry,
magnetic susceptibility measurements, and UVâvis complex formation
studies (for <b>1</b>) as well as by X-ray crystallography (<b>1</b> and <b>2</b>). The antiproliferative activity of <sup><b>EtOOC</b></sup><b>HL</b><sup><b>COOEt</b></sup>, <b>1</b>, and <b>2</b> was determined by the MTT assay
in three human cancer cell lines, namely, A549 (nonsmall cell lung
carcinoma), CH1 (ovarian carcinoma), and SW480 (colon adenocarcinoma),
yielding IC<sub>50</sub> values in the micromolar concentration range
and showing dependence on the cell line. The effect of metal coordination
on cytotoxicity of <sup><b>EtOOC</b></sup><b>HL</b><sup><b>COOEt</b></sup> is also discussed. The subcellular distribution
of <sup><b>EtOOC</b></sup><b>HL</b><sup><b>COOEt</b></sup> and <b>2</b> was investigated by fluorescence microscopy,
revealing similar localization for both compounds in cytoplasmic structures